Cargando…

Biomarkers of bacterial translocation in advanced chronic liver disease: the key to individualizing prognosis

Detalles Bibliográficos
Autores principales:	Majumdar, Avik, Tsochatzis, Emmanuel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hellenic Society of Gastroenterology 2016
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4700840/ https://www.ncbi.nlm.nih.gov/pubmed/26751221

Ejemplares similares

Multi-disciplinary clinic models for the management of non-alcoholic fatty liver disease
por: Zoncapè, Mirko, et al.
Publicado: (2022)

The Gut Microbiota, Intestinal Permeability, Bacterial Translocation, and Nonalcoholic Fatty Liver Disease: What Comes First?
por: Spengler, Erin, et al.
Publicado: (2015)

Role of pregnane X-receptor in regulating bacterial translocation in chronic liver diseases
por: Mohandas, Sundhar, et al.
Publicado: (2017)

Microbial Translocation in Chronic Liver Diseases
por: Pinzone, Marilia Rita, et al.
Publicado: (2012)

Bacterial translocation markers in liver cirrhosis
por: Alexopoulou, Alexandra, et al.
Publicado: (2017)

Natural History of Nonalcoholic Fatty Liver Disease: Implications for Clinical Practice and an Individualized Approach
por: Grgurevic, Ivica, et al.
Publicado: (2020)

Advances in the Progression and Prognosis Biomarkers of Chronic Kidney Disease
por: Yan, Zhonghong, et al.
Publicado: (2021)

Metabolic associated fatty liver disease: Addressing a new era in liver transplantation
por: Gill, Madeleine G, et al.
Publicado: (2020)

Case-finding strategies in non-alcoholic fatty liver disease
por: Boursier, Jerome, et al.
Publicado: (2020)

Elevation of enterococcus-specific antibodies associated with bacterial translocation is predictive of survival rate in chronic liver disease
por: Iwasa, Motoh, et al.
Publicado: (2022)

Basic and Clinical Advances in Chronic Liver Inflammation
por: Enomoto, Hirayuki, et al.
Publicado: (2016)

Is lifestyle Modification the Key to Counter Chronic Diseases?
por: Mitrou, Panagiota
Publicado: (2022)

Gut Microbiota and Bacterial Translocation in the Pathogenesis of Liver Fibrosis
por: Maslennikov, Roman, et al.
Publicado: (2023)

Bacterial translocation in patients undergoing major gastrointestinal surgery and its role in postoperative sepsis
por: Doudakmanis, Christos, et al.
Publicado: (2021)

Recent Advancements in Tracking Bacterial Effector Protein Translocation
por: Braet, Julie, et al.
Publicado: (2022)

Advances in Alcoholic Liver Disease
por: Osna, Natalia, et al.
Publicado: (2012)

Advancing proteomics and machine learning in the clinic: an editorial on “Noninvasive proteomic biomarkers for alcohol-related liver disease”
por: McGinnis, Courtney D., et al.
Publicado: (2022)

Microbial Translocation and Infectious Diseases: What Is the Link?
por: D'Ettorre, Gabriella, et al.
Publicado: (2012)

Changes in gut bacterial populations and their translocation into liver and ascites in alcoholic liver cirrhotics
por: Tuomisto, Sari, et al.
Publicado: (2014)

Beyond Liver Disease: Non-Alcoholic Fatty Liver Disease and Advanced Liver Fibrosis in Kidney Disease
por: Han, Eugene
Publicado: (2022)

Advances in Biomarkers and Diagnostics in Periodontitis and Oral Diseases
por: Isola, Gaetano
Publicado: (2021)

Advances in Chronic Kidney Disease
por: Parrish, Alan R.
Publicado: (2016)

Noninvasive Assessment of Fibrosis in Patients with Nonalcoholic Fatty Liver Disease
por: Buzzetti, Elena, et al.
Publicado: (2015)

Lactate as a Biomarker for Sepsis Prognosis?
por: Kang, Ha Eun, et al.
Publicado: (2016)

Food Contact Materials: Migration and Analysis. Challenges and Limitations on Identification and Quantification
por: Tsochatzis, Emmanouil D.
Publicado: (2021)

Non-invasive biomarkers of liver fibrosis in non-alcoholic fatty liver disease
por: Basheer, Maamon, et al.
Publicado: (2023)

Key Advances in Intensive Care and the Coronavirus Disease-19 Research and Practice Boost
por: Mentzelopoulos, Spyros D., et al.
Publicado: (2022)

Adoptive T-cell therapy to treat liver cancer: Is the liver microenvironment key?
por: Willimsky, Gerald, et al.
Publicado: (2013)

Preoperative Considerations in Patients with Advanced Liver Disease
por: Aminnejad, Reza, et al.
Publicado: (2019)

Increased gut permeability and bacterial translocation are associated with fibromyalgia and myalgic encephalomyelitis/chronic fatigue syndrome: implications for disease-related biomarker discovery
por: Martín, Franz, et al.
Publicado: (2023)

Nonalcoholic fatty liver disease in lean subjects: Prognosis, outcomes and management
por: Chrysavgis, Lampros, et al.
Publicado: (2020)

Biomarkers in Liver Disease: Emerging Methods and Potential Applications
por: Aithal, Guruprasad P., et al.
Publicado: (2012)

Bacterial Translocation as Inflammatory Driver in Crohn’s Disease
por: Linares, Raquel, et al.
Publicado: (2021)

Non-invasive assessment of liver fibrosis
por: Papastergiou, Vasilios, et al.
Publicado: (2012)

Pathophysiology of Chronic Liver Disease Development
por: Fromme, Malin, et al.
Publicado: (2022)

Baveno VII criteria to predict decompensation in compensated advanced chronic liver disease: Still some shades of grey
por: Rodrigues, Susana G.
Publicado: (2023)

Medication Requirements for Disease Control Predict the Prognosis of Chronic Urticaria
por: Choi, Jeong-Hee
Publicado: (2021)

Biomarkers of Oxidative Stress in Acute and Chronic Diseases
por: Massaccesi, Luca, et al.
Publicado: (2022)

What are the key points in the association between the gut microbiome and nonalcoholic fatty liver disease?
por: Vallianou, Natalia, et al.
Publicado: (2019)

Vitamin A in Nonalcoholic Fatty Liver Disease: A Key Player in an Offside Position?
por: Berasain, Carmen, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gt7b1qko55o80fdid6leio50vl